Trump vows to lower drug prices in the US by up to 80%

Open the newsletter to watch the White House for free

Your guide to what the second period of Trump means to Washington, business and the world

Donald Trump is planning to use his executive powers to force pharmaceutical companies to reduce the cost of medicines in the United States significantly, despite the intense opposition of this industry and some major Republicans.

In a post on social media on Sunday evening, Trump said he would sign an order on Monday that would reduce prices “immediately by about 30 percent to 80 percent.”

He added that the United States will provide the “most preferred nation” policy, “as the United States will pay the same price of the nation that pays the lowest price anywhere in the world.”

Trump tried a similar step during his first term in office, but failed to advance amid strong resistance to the pharmaceutical industry.

The US president has now suggested that he see any opposition from the sector, although large pharmaceutical groups and commercial bodies made donations to install him.

Trump added to the social truth: “The contributions of the Wonder campaign can do, but not with me, and not with the Republican Party,” Trump added to the social truth. “We will do the right thing, which is something that Democrats have fought for many years.”

In response to the proposed executive order, the Perma Phena Industry Group said, “The preparation of government prices in any way is bad for American patients.” “To reduce the costs of medicine for Americans, we must deal with the increasing share of the costs of medicines that go to the mediators in the system.”

The group was one of many representative bodies that filed a lawsuit against the recent Trump administration for trying to restrict medicines – which eventually prompted Biden the White House to completely drop the proposals.

After that, the Biden Administration included a negotiation of drugs in the law to reduce inflation, targeting 10 specific drugs in a step estimated to provide nearly $ 100 billion over a period of ten years. This step has also prompted a large number of lawsuits from the pharmaceutical industry, but most of them have not yet succeeded.

The sector also launched a public relations campaign, claiming such plans that discourage innovation and reduce research spending.

Trump rejected the allegations in his position, as he wrote that drug companies “will say, for years, that the costs of research and development, and that all these costs were, and will not be, without reason, to be carried by” the suckers “in America, alone.”

He claimed that as a result of the expected arrangement, “our country will finally be dealt with fairly.”

According to what was reported, White House officials tried to impose the ruling on reducing drug prices in a budget bill looming on the horizon, but they faced a decline from some of the major Republicans, including parliament Speaker Mike Johnson.